Combined ivermectin and intense pulsed light therapy can help resolve Demodex blepharitis and prevent its recurrence.

Tarsus Pharmaceuticals' lotilaner shows strong market performance for Demodex blepharitis, but cautious investment due to ...

Dealing with red, itchy eyelids? The culprit could be a common mite. This article is sponsored by XDEMVY. Dr. Watson is a ...

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management will participate in fireside chats at two ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $60.0, a high ...

We recently published a list of Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks. In this article, we are going to ...

Eyelash mites might sound like something out of a horror story, but they’re more common than you think. These microscopic creatures, known as Demodex mites, live on nearly everyone’s skin. For most, ...

Tarsus Pharmaceuticals (NASDAQ:TARS – Get Free Report) had its price objective lifted by equities researchers at Barclays ...

Good news—most of these eyelash loss mistakes are easily fixed. Just like the hair on your head, it’s completely normal to ...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) was up 9% during trading on Monday after Barclays raised their ...